Mission statement · Company scope
“Our mission is to transform the treatment of rare diseases and expand the availability of transplantable organs through innovative organ manufacturing technologies.”
In use2026 – now1 sighting
First seenFeb 2026Added
Last seenFeb 2026Latest observation
Date created—Not published by the organization
Record
- Kind
- Mission
- Scope
- Company
- Style
- Innovation (primary) · Impact
- Leads with
- Invention
- Best for
- Climate & health
- Formula
- We’re building [new thing] so [result]
- Tone
- Technical
- Length
- 22 words · reading grade 18.2
- Review status
- unreviewed · classifier rules-v0
- Quality score
- 0.75
- Record
- st_0eab9493f4f45d93
- Classification confidence
- 0.79
Sources1 sighting
SEC
SEC EDGAR filingsObserved 2026-02-25 · sec_sentence · 10-K · accession 0001082554-26-000006
View filing ↗0 to compareCompare